Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques P Tremblay

Showing results (81-90 of 139) with videos related to

Pageof 14
Sort By:
Cell Transplantation|August 29, 2017
Online Manuscript Processing for Cell TransplantationPaul R Sanberg, Camillo Ricordi, Jacques P Tremblay, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 8, 2010
Intramuscular transplantation of human postnatal myoblasts generates functional donor-derived satellite cellsDaniel Skuk, Martin Paradis, Marlyne Goulet, et al.
Molecular Therapy. Nucleic Acids|April 5, 2021
Base editing strategy for insertion of the A673T mutation in the APP gene to prevent the development of AD <i>in vitro</i>Antoine Guyon, Joël Rousseau, Francis-Gabriel Bégin, et al.
Transplantation|March 9, 2002
Treatment with anti-CD154 antibody and donor-specific transfusion prevents acute rejection of myoblast transplantationGeoffrey Camirand, Nicolas J Caron, Nicole A Turgeon, et al.
Molecular Therapy. Nucleic Acids|September 10, 2018
Increased Frataxin Expression Induced in Friedreich Ataxia Cells by Platinum TALE-VP64s or Platinum TALE-SunTagKhadija Cherif, Catherine Gérard, Joël Rousseau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2022
Serum extracellular vesicles for delivery of CRISPR-CAS9 ribonucleoproteins to modify the dystrophin geneNathalie Majeau, Annabelle Fortin-Archambault, Catherine Gérard, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 26, 2017
From gRNA Identification to the Restoration of Dystrophin Expression: A Dystrophin Gene Correction Strategy for Duchenne Muscular Dystrophy Mutations Using the CRISPR-Induced Deletion MethodBenjamin Duchêne, Jean-Paul Iyombe-Engembe, Joël Rousseau, et al.
Human Gene Therapy|June 18, 2010
Electrotransfer of the full-length dog dystrophin into mouse and dystrophic dog musclesChristophe Pichavant, Pierre Chapdelaine, Daniel G Cerri, et al.
Biotechniques|July 16, 2005
Real-time imaging of myoblast transplantation using the human sodium iodide symporterManaf Bouchentouf, Basma F Benabdallah, Marcel Dumont, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 5, 2010
Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophySébastien Goudenege, Yann Lamarre, Nicolas Dumont, et al.
Pageof 14

Showing results (81-90 of 139) with videos related to

Sort By:
Pageof 14
Cell Transplantation|August 29, 2017
Online Manuscript Processing for Cell TransplantationPaul R Sanberg, Camillo Ricordi, Jacques P Tremblay, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 8, 2010
Intramuscular transplantation of human postnatal myoblasts generates functional donor-derived satellite cellsDaniel Skuk, Martin Paradis, Marlyne Goulet, et al.
Molecular Therapy. Nucleic Acids|April 5, 2021
Base editing strategy for insertion of the A673T mutation in the APP gene to prevent the development of AD <i>in vitro</i>Antoine Guyon, Joël Rousseau, Francis-Gabriel Bégin, et al.
Transplantation|March 9, 2002
Treatment with anti-CD154 antibody and donor-specific transfusion prevents acute rejection of myoblast transplantationGeoffrey Camirand, Nicolas J Caron, Nicole A Turgeon, et al.
Molecular Therapy. Nucleic Acids|September 10, 2018
Increased Frataxin Expression Induced in Friedreich Ataxia Cells by Platinum TALE-VP64s or Platinum TALE-SunTagKhadija Cherif, Catherine Gérard, Joël Rousseau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2022
Serum extracellular vesicles for delivery of CRISPR-CAS9 ribonucleoproteins to modify the dystrophin geneNathalie Majeau, Annabelle Fortin-Archambault, Catherine Gérard, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 26, 2017
From gRNA Identification to the Restoration of Dystrophin Expression: A Dystrophin Gene Correction Strategy for Duchenne Muscular Dystrophy Mutations Using the CRISPR-Induced Deletion MethodBenjamin Duchêne, Jean-Paul Iyombe-Engembe, Joël Rousseau, et al.
Human Gene Therapy|June 18, 2010
Electrotransfer of the full-length dog dystrophin into mouse and dystrophic dog musclesChristophe Pichavant, Pierre Chapdelaine, Daniel G Cerri, et al.
Biotechniques|July 16, 2005
Real-time imaging of myoblast transplantation using the human sodium iodide symporterManaf Bouchentouf, Basma F Benabdallah, Marcel Dumont, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 5, 2010
Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophySébastien Goudenege, Yann Lamarre, Nicolas Dumont, et al.
Pageof 14